16-54931434-TCTC-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_005853.6(IRX5):βc.240_242delβ(p.Ser81del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.000158 in 1,587,832 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.00016 ( 0 hom., cov: 33)
Exomes π: 0.00016 ( 1 hom. )
Consequence
IRX5
NM_005853.6 inframe_deletion
NM_005853.6 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.46
Genes affected
IRX5 (HGNC:14361): (iroquois homeobox 5) This gene encodes a member of the iroquois homeobox gene family, which are involved in several embryonic developmental processes. Knockout mice lacking this gene show that it is required for retinal cone bipolar cell differentiation, and that it negatively regulates potassium channel gene expression in the heart to ensure coordinated cardiac repolarization. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_005853.6. Strenght limited to Supporting due to length of the change: 1aa.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRX5 | NM_005853.6 | c.240_242del | p.Ser81del | inframe_deletion | 1/3 | ENST00000394636.9 | NP_005844.4 | |
IRX5 | NM_001252197.1 | c.240_242del | p.Ser81del | inframe_deletion | 1/3 | NP_001239126.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRX5 | ENST00000394636.9 | c.240_242del | p.Ser81del | inframe_deletion | 1/3 | 3 | NM_005853.6 | ENSP00000378132 | A1 | |
IRX5 | ENST00000320990.9 | c.240_242del | p.Ser81del | inframe_deletion | 1/3 | 1 | ENSP00000316250 | P4 | ||
IRX5 | ENST00000560154.5 | c.240_242del | p.Ser81del | inframe_deletion | 1/3 | 5 | ENSP00000453660 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152104Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
25
AN:
152104
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000231 AC: 48AN: 207514Hom.: 1 AF XY: 0.000181 AC XY: 21AN XY: 116326
GnomAD3 exomes
AF:
AC:
48
AN:
207514
Hom.:
AF XY:
AC XY:
21
AN XY:
116326
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000157 AC: 226AN: 1435614Hom.: 1 AF XY: 0.000167 AC XY: 119AN XY: 713984
GnomAD4 exome
AF:
AC:
226
AN:
1435614
Hom.:
AF XY:
AC XY:
119
AN XY:
713984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74418
GnomAD4 genome
AF:
AC:
25
AN:
152218
Hom.:
Cov.:
33
AF XY:
AC XY:
10
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | The c.240_242delCTC (p.S81del) alteration is located in exon 1 (coding exon 1) of the IRX5 gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions c.240 and c.242, resulting in the deletion of 1 residue. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Craniofacial dysplasia - osteopenia syndrome Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Baylor Genetics | May 01, 2016 | Our laboratory reported dual molecular diagnoses in IRX5 (NM_005853.5:c.1362_1368delinsGT; NM_005853.5:c.240_242delCTC; in trans) and HDAC8 (NM_018486.2:c.527A>G) in an individual with delayed motor milestones, short stature, delayed speech, intellectual disability, failure to thrive, hypotonia, dysmorphic features, microcephaly, mild hearing loss, myopia, and skeletal abnormalities. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at